Skip to main content
SpringerLink
Log in

Sospensione dei bisfosfonati e persistenza degli effetti terapeutici

  • SALUTE DELL’OSSO/VITAMINA D
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. Eriksen EF, Díez-Pérez A, Boonen S (2014) Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: a systematic review. Bone 58:126–135

    Article  CAS  Google Scholar 

  2. Black DM, Schwartz AV, Ensrud KE et al. (2006) Effects of continuing or stopping alendronate after 5 years of treatment. The Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 296(24):2927–2938

    Article  CAS  Google Scholar 

  3. Black DM, Reid IR, Boonen S et al. (2012) The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res 27(2):243–254

    Article  CAS  Google Scholar 

  4. Reginster J, Minne HW, Sorensen OH et al. (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11(1):83–91

    Article  CAS  Google Scholar 

  5. Commissione Intersocietaria per l’Osteoporosi (2017) Linee Guida sulla gestione dell’Osteoporosi e delle Fratture da fragilità

  6. Idolazzi L, Fassio A, Gatti D et al. (2013) Duration of treatment for osteoporosis. Reumatismo 65(1):22–35

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Messina, Messina, Italia

    Federica Bellone, Nunziata Morabito, Francesco Corica & Antonino Catalano

Authors
  1. Federica Bellone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nunziata Morabito
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesco Corica
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antonino Catalano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antonino Catalano.

Ethics declarations

Conflitto di interesse

Gli autori Federica Bellone, Nunziata Morabitoe Francesco Corica e Antonino Catalano dichiarano di non avere conflitti di interesse.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Gli autori di questo articolo non hanno eseguito studi sugli animali.

Additional information

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bellone, F., Morabito, N., Corica, F. et al. Sospensione dei bisfosfonati e persistenza degli effetti terapeutici. L'Endocrinologo 22 (Suppl 1), 74–76 (2021). https://doi.org/10.1007/s40619-021-00892-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-021-00892-7

Search

Navigation